PTC Therapeutics, Inc. (PTCT) Revenue 2016–2025
PTC Therapeutics, Inc. (PTCT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.7BFY2025 · since FY2016: $82.7M → $1.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.7B | +114.5% |
| FY2024 | $806.8M | -14.0% |
| FY2023 | $937.8M | +34.2% |
| FY2022 | $698.8M | +29.7% |
| FY2021 | $538.6M | +41.4% |
| FY2020 | $380.8M | +24.0% |
| FY2019 | $307.0M | +16.0% |
| FY2018 | $264.7M | +36.2% |
| FY2017 | $194.4M | +135.0% |
| FY2016 | $82.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice